0001683168-19-002236.txt : 20190718
0001683168-19-002236.hdr.sgml : 20190718
20190718153928
ACCESSION NUMBER: 0001683168-19-002236
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190718
DATE AS OF CHANGE: 20190718
EFFECTIVENESS DATE: 20190718
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xenetic Biosciences, Inc.
CENTRAL INDEX KEY: 0001534525
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452952962
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-344619
FILM NUMBER: 19961304
BUSINESS ADDRESS:
STREET 1: 40 SPEEN STREET, SUITE 102
CITY: FRAMINGHAM
STATE: MA
ZIP: 01701
BUSINESS PHONE: 781-778-7720
MAIL ADDRESS:
STREET 1: 40 SPEEN STREET, SUITE 102
CITY: FRAMINGHAM
STATE: MA
ZIP: 01701
FORMER COMPANY:
FORMER CONFORMED NAME: General Sales & Leasing, Inc.
DATE OF NAME CHANGE: 20130227
FORMER COMPANY:
FORMER CONFORMED NAME: GENERAL AIRCRAFT INC.
DATE OF NAME CHANGE: 20111108
D
1
primary_doc.xml
X0708
D
LIVE
0001534525
Xenetic Biosciences, Inc.
40 SPEEN STREET, SUITE 102
FRAMINGHAM
MA
MASSACHUSETTS
01701
781-778-7720
NEVADA
None
General Sales & Leasing, Inc.
GENERAL AIRCRAFT INC.
Corporation
true
Jeffrey
Eisenberg
40 Speen Street, Suite 102
Framingham
MA
MASSACHUSETTS
01701
Executive Officer
Director
James
Callaway
40 Speen Street, Suite 102
Framingham
MA
MASSACHUSETTS
01701
Director
Firdaus
Dastoor
40 Speen Street, Suite 102
Framingham
MA
MASSACHUSETTS
01701
Director
Dmitry
Genkin
40 Speen Street, Suite 102
Framingham
MA
MASSACHUSETTS
01701
Director
Roman
Knyazev
40 Speen Street, Suite 102
Framingham
MA
MASSACHUSETTS
01701
Director
Roger
Kornberg
40 Speen Street, Suite 102
Framingham
MA
MASSACHUSETTS
01701
Director
Adam
Logal
40 Speen Street, Suite 102
Framingham
MA
MASSACHUSETTS
01701
Director
Curtis
Lockshin
40 Speen Street, Suite 102
Framingham
MA
MASSACHUSETTS
01701
Director
James
Parslow
40 Speen Street, Suite 102
Framingham
MA
MASSACHUSETTS
01701
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2019-07-03
false
true
true
true
false
0
251508
251508
0
false
3
0
0
0
false
Xenetic Biosciences, Inc.
/s/ James Parslow
James Parslow
Chief Financial Officer
2019-07-18